Sign Up to like & get
recommendations!
0
Published in 2019 at "Cancer Research"
DOI: 10.1158/1538-7445.panca19-c59
Abstract: The current 5-year survival rate of pancreatic ductal adenocarcinoma (PDAC) is ~8%. The dismal prognosis in PDAC reflects in part an exceptional level of resistance to available therapies. Approximately half of PDAC patients present with…
read more here.
Keywords:
pdac;
pdac cells;
radiation;
nrf2 drives ... See more keywords